Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
Stevo Julius(University of Michigan–Ann Arbor), Sverre E. Kjeldsen(University of Michigan–Ann Arbor), Michael A. Weber(State University of New York), Hans R. Brunner(University of Lausanne), Steffan Ekman(Novartis (Switzerland)), Lennart Hansson(Uppsala University), Tsushung A. Hua(Novartis (United States)), John H. Laragh(NewYork–Presbyterian Hospital), Gordon T. McInnes(University of Glasgow), Lada Mitchell(Novartis (Switzerland)), Francis Plat(Novartis (Switzerland)), Anthony Schork(University of Michigan–Ann Arbor), Beverly A. Smith(Novartis (United States)), Alberto Zanchetti(Ospedale Maggiore)
Cited by 2,547
Abstract
Related Papers
No related papers found
Powered by citation graph analysis